Medartis Holding AG (MED.SW) Stock
Medartis Holding AG is a global medical technology firm that develops, manufactures, and distributes implantable solutions. These advanced medical devices are utilized worldwide for the surgical stabilization of bone fractures in both the upper and lower extremities, in addition to addressing complex cranio-maxillofacial surgical needs.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Peer Comparison
About Medartis Holding AG
Medartis Holding AG is a global medical technology firm that develops, manufactures, and distributes implantable solutions. These advanced medical devices are utilized worldwide for the surgical stabilization of bone fractures in both the upper and lower extremities, in addition to addressing complex cranio-maxillofacial surgical needs. The company's portfolio features osteosynthesis instruments, marketed under the APTUS and MODUS brands, specifically designed for various body regions including the hand, wrist, elbow, shoulder, foot, and ankle, as well as for facial and skull procedures involving the mandible, midface, orthognathic structures, and cranium. Medartis serves a diverse clientele comprising surgeons, hospitals, medical centers, and group purchasing organizations. The company, founded in 1997, is headquartered in Basel, Switzerland.
Medartis Holding AG is led by CEO Matthias Schupp, employs 1,259 people, headquartered in Basel, CH, publicly traded since 2018.
over the past 52 weeks the stock has ranged between $70.60 and $97.50, and currently trades 12.8% below its 52-week high.
Official website: www.medartis.com